ArticleKidney international reports2026

Potential Benefit of Sodium-Glucose Cotransporter 2-Inhibitors in Cisplatin-Associated Nephrotoxicity Among Patients With Cancer Having Diabetes Mellitus.

Juan J Cintrón-García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.